Carl Icahn
Icahn Capital Management
Carl Icahn Bausch Health Companies Inc stake
total: 71
Icahn Capital Management BHC trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Held since:
- 2020 Q4
- Held for:
- 19 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Carl Icahn doesn't hold any Bausch Health Companies Inc (BHC) shares. To date, the estimated cost basis is nearly $30.08 for "buy" trades and estimated average "sell" price is $6.66. Icahn Capital Management first purchased BHC in 2020 Q4, initially acquiring about 5.03M shares. Since the initial investment in Bausch Health Companies Inc (BHC), Icahn Capital Management has made 3 more transactions.
When did Carl Icahn sell Bausch Health Companies Inc (BHC)?
Carl Icahn sold off the entire Bausch Health Companies Inc (BHC) position in 2025 Q3.
When did Carl Icahn buy Bausch Health Companies Inc (BHC)?
Carl Icahn first invested in Bausch Health Companies Inc (BHC) in 2020 Q4 at the reported quarter-end price of $20.80 per share.
What's the cost basis of Icahn Capital Management's BHC stake?
The estimated cost basis for Bausch Health Companies Inc (BHC) stake is around $30.08 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $30.08
- Weighted AVG sell price:
- $6.66
Carl Icahn's historical trades in Bausch Health Companies Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$6.66
|
|
-100% (-34,721,118)
|
-2.93%
|
|
2021 Q4
|
4.30%
|
34,721,118
|
$27.61
|
$958,650,000
|
+1.79% (+611,966)
|
+0.08%
|
|
2021 Q1
|
4.54%
|
34,109,152
|
$31.74
|
$1,082,624,000
|
+577.69% (+29,076,005)
|
+3.87%
|
|
2020 Q4
|
0.52%
|
$20.80
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.